Updated Jul 16, 2026
Ma Yingli is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-23 | GPCR | Structure Therapeutics Inc. | A — Grant or award | 32.5K | $0.00 | |
| 2026-03-05 | GPCR | Structure Therapeutics Inc. | F — Tax withholding / forfeiture | 11.3K | $20.99 | $237K |
| 2025-07-01 | GPCR | Structure Therapeutics Inc. | F — Tax withholding / forfeiture | 4.5K | $6.84 | $31K |
| 2025-03-01 | GPCR | Structure Therapeutics Inc. | A — Grant or award | 24.5K | $0.00 | |
| 2025-03-01 | GPCR | Structure Therapeutics Inc. | F — Tax withholding / forfeiture | 1.8K | $7.92 | $14K |
Ma Yingli is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ma Yingli profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.